Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neoplasms × Observation × Clear all

Phase

Status

Sponsor Class

OTHER 10 INDUSTRY 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Prostatic Neoplasms 2 Neuroblastoma 2 Leukemia, Myeloid, Acute 2 Endometrial Neoplasms 2 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Pleuropulmonary blastoma 1 Papillomavirus Infections 1 Pain 1 Neurofibrosarcoma 1 Neoplasms 1 Myeloproliferative Syndrome, Transient 1 Meningioma 1 Melanoma 1 Malignant mesenchymal tumor 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hepatoblastoma 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Surveys and Questionnaires 2 Proton Therapy 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Busulfan 2 tremelimumab 1 motesanib diphosphate 1 luprolide acetate gel depot 1 liposomal amphotericin B 1 durvalumab 1 copanlisib 1 chlorhexidine gluconate 1 batifiban 1 Whole Genome Sequencing 1 Watchful Waiting 1 Thrombopoietin 1 Taxes 1 Spermine Synthase 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Psychiatrists 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡